MedPath

MALLINCKRODT UK FINANCE LLP

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

Phase 3
Completed
Conditions
Chronic Pain
Interventions
First Posted Date
2008-03-07
Last Posted Date
2020-09-16
Lead Sponsor
Mallinckrodt
Target Recruit Count
343
Registration Number
NCT00631319

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

Phase 3
Completed
Conditions
Idiopathic Pulmonary Arterial Hypertension
Cardiomyopathy
Interventions
Drug: Nitric Oxide for inhalation
Drug: Nitric Oxide plus Oxygen
First Posted Date
2008-02-29
Last Posted Date
2019-12-20
Lead Sponsor
Mallinckrodt
Target Recruit Count
136
Registration Number
NCT00626028
Locations
🇺🇸

Columbus Children's Hospital, Columbus, Ohio, United States

🇫🇷

CHU Timone - Département de cardiologie, Marseille, France

🇪🇸

Hospital Gregorio Maranon, Madrid, Spain

and more 15 locations

Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients

Phase 3
Completed
Conditions
Acute Pain
Fever
Interventions
First Posted Date
2008-01-22
Last Posted Date
2016-10-21
Lead Sponsor
Mallinckrodt
Target Recruit Count
213
Registration Number
NCT00598559
Locations
🇺🇸

Huntington Memorial Hospital, Pasadena, California, United States

🇺🇸

Santa Barbara Cottage Hospital, Santa Barbara, California, United States

🇺🇸

Nature Coast Clinical Research, Crystal River, Florida, United States

and more 11 locations

Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients

Phase 3
Completed
Conditions
Fever
Pain
Interventions
First Posted Date
2008-01-22
Last Posted Date
2017-05-10
Lead Sponsor
Mallinckrodt
Target Recruit Count
100
Registration Number
NCT00598702
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

SUNY Stony Brook, Stony Brook, New York, United States

🇺🇸

Baylor College of Medicine, Houston, Texas, United States

and more 11 locations

Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis

Phase 1
Completed
Conditions
Cystic Fibrosis
Interventions
Drug: Nitric Oxide for Inhalation
First Posted Date
2007-12-10
Last Posted Date
2019-11-13
Lead Sponsor
Mallinckrodt
Target Recruit Count
18
Registration Number
NCT00570349
Locations
🇺🇸

The Children's Hospital, Denver, Colorado, United States

Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation

Phase 2
Completed
Conditions
Lung Transplantation
Interventions
First Posted Date
2007-12-10
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Target Recruit Count
49
Registration Number
NCT00570245
Locations
🇪🇸

Hospital General La Fe, Valencia, Spain

Nitric Oxide in Myocardial Infarction Size

Phase 2
Terminated
Conditions
STEMI
Acute Myocardial Infarction
ST Elevation MI
Interventions
Drug: Placebo
First Posted Date
2007-12-05
Last Posted Date
2019-11-21
Lead Sponsor
Mallinckrodt
Target Recruit Count
29
Registration Number
NCT00568061
Locations
🇧🇪

Virga Jesse Hospital, Hasselt, Belgium

🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 11 locations

Study of the Efficacy and Safety of Intravenous vs Oral Acetaminophen for Treatment of Fever in Healthy Adult Males

Phase 3
Completed
Conditions
Fever
Interventions
First Posted Date
2007-11-28
Last Posted Date
2016-10-19
Lead Sponsor
Mallinckrodt
Target Recruit Count
105
Registration Number
NCT00564629
Locations
🇺🇸

New Orleans Center for Clinical Research-Knoxville, Knoxville, Tennessee, United States

Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain

Phase 3
Completed
Conditions
Pain
Interventions
Drug: IV Placebo
First Posted Date
2007-11-28
Last Posted Date
2016-10-21
Lead Sponsor
Mallinckrodt
Target Recruit Count
244
Registration Number
NCT00564486
Locations
🇺🇸

Cooper University Hospital, Camden, New Jersey, United States

🇺🇸

Huntington Memorial Hospital, Pasadena, California, United States

🇺🇸

Physicians Clinical Research Corporation, Laguna Hills, California, United States

and more 14 locations

Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies

Phase 3
Completed
Conditions
Lung Disease
Interventions
Drug: Placebo
First Posted Date
2007-10-31
Last Posted Date
2021-02-05
Lead Sponsor
Mallinckrodt
Target Recruit Count
800
Registration Number
NCT00551642
Locations
🇧🇪

Clinique St. Vincent CHC, Rocourt, Belgium

🇳🇱

Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands

🇮🇹

Policlinico S. Orsola, Bologna, Italy

and more 32 locations
© Copyright 2025. All Rights Reserved by MedPath